In terms of global exposure overall to the fraud claims that can be brought under 10b-5, the report stated, 2Q of 2025 saw ...

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the proposed Settlement in the Spectrum Pharmaceuticals, Inc. Litigation: SPECTRUM PHARAMCEUTICALS, INC., et al.